Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies

Conflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this meta-analysis focuses on the relationship between vitamin D intervention and glycaemic control in subjects with T2D. We reviewed available randomized c...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 98; no. 14; p. e14970
Main Authors Hu, Zhiwei, Chen, Jin’an, Sun, Xinjuan, Wang, Lei, Wang, Aiping
Format Journal Article
LanguageEnglish
Published United States the Author(s). Published by Wolters Kluwer Health, Inc 01.04.2019
Wolters Kluwer Health
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Conflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this meta-analysis focuses on the relationship between vitamin D intervention and glycaemic control in subjects with T2D. We reviewed available randomized controlled trials (RCTs) studies from the establishment time of each database to March 31, 2018. Stata 13.0 software was used to evaluate the included literature. Finally, a total of 19 RCT studies involving 747 intervention subjects and 627 placebo controls were included in this meta-analysis. Meta-analysis results showed that compared with the control group, the short-term vitamin D supplementation group had a decline in hemoglobin A1c (HbA1c), insulin resistance, and insulin. The Standard Mean Difference (SMD) (95% CI [95% confidence interval]) of HbA1c, insulin resistance, and insulin were -0.17 (-0.29, -0.05), -0.75 (-0.97, -0.53), -0.57 (-0.78, -0.35), respectively with all P value <.05. But there were no significant differences in long-term follow-up vitamin D intervention. Vitamin D supplementation in T2D patients can improve HbA1c, insulin resistance, and insulin in short-term intervention, suggesting that vitamin D can be considered as a therapeutic agent along with the other treatments for T2D.
AbstractList Supplemental Digital Content is available in the text
Conflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this meta-analysis focuses on the relationship between vitamin D intervention and glycaemic control in subjects with T2D. We reviewed available randomized controlled trials (RCTs) studies from the establishment time of each database to March 31, 2018. Stata 13.0 software was used to evaluate the included literature. Finally, a total of 19 RCT studies involving 747 intervention subjects and 627 placebo controls were included in this meta-analysis. Meta-analysis results showed that compared with the control group, the short-term vitamin D supplementation group had a decline in hemoglobin A1c (HbA1c), insulin resistance, and insulin. The Standard Mean Difference (SMD) (95% CI [95% confidence interval]) of HbA1c, insulin resistance, and insulin were -0.17 (-0.29, -0.05), -0.75 (-0.97, -0.53), -0.57 (-0.78, -0.35), respectively with all P value <.05. But there were no significant differences in long-term follow-up vitamin D intervention. Vitamin D supplementation in T2D patients can improve HbA1c, insulin resistance, and insulin in short-term intervention, suggesting that vitamin D can be considered as a therapeutic agent along with the other treatments for T2D.
Conflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this meta-analysis focuses on the relationship between vitamin D intervention and glycaemic control in subjects with T2D.BACKGROUNDConflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this meta-analysis focuses on the relationship between vitamin D intervention and glycaemic control in subjects with T2D.We reviewed available randomized controlled trials (RCTs) studies from the establishment time of each database to March 31, 2018. Stata 13.0 software was used to evaluate the included literature.METHODSWe reviewed available randomized controlled trials (RCTs) studies from the establishment time of each database to March 31, 2018. Stata 13.0 software was used to evaluate the included literature.Finally, a total of 19 RCT studies involving 747 intervention subjects and 627 placebo controls were included in this meta-analysis. Meta-analysis results showed that compared with the control group, the short-term vitamin D supplementation group had a decline in hemoglobin A1c (HbA1c), insulin resistance, and insulin. The Standard Mean Difference (SMD) (95% CI [95% confidence interval]) of HbA1c, insulin resistance, and insulin were -0.17 (-0.29, -0.05), -0.75 (-0.97, -0.53), -0.57 (-0.78, -0.35), respectively with all P value <.05. But there were no significant differences in long-term follow-up vitamin D intervention.RESULTSFinally, a total of 19 RCT studies involving 747 intervention subjects and 627 placebo controls were included in this meta-analysis. Meta-analysis results showed that compared with the control group, the short-term vitamin D supplementation group had a decline in hemoglobin A1c (HbA1c), insulin resistance, and insulin. The Standard Mean Difference (SMD) (95% CI [95% confidence interval]) of HbA1c, insulin resistance, and insulin were -0.17 (-0.29, -0.05), -0.75 (-0.97, -0.53), -0.57 (-0.78, -0.35), respectively with all P value <.05. But there were no significant differences in long-term follow-up vitamin D intervention.Vitamin D supplementation in T2D patients can improve HbA1c, insulin resistance, and insulin in short-term intervention, suggesting that vitamin D can be considered as a therapeutic agent along with the other treatments for T2D.CONCLUSIONVitamin D supplementation in T2D patients can improve HbA1c, insulin resistance, and insulin in short-term intervention, suggesting that vitamin D can be considered as a therapeutic agent along with the other treatments for T2D.
Author Wang, Aiping
Hu, Zhiwei
Wang, Lei
Sun, Xinjuan
Chen, Jin’an
AuthorAffiliation Department of Endocrinology, 454 Hospital Affiliated to People's Liberation Army, Nanjing, Jiangsu Province, China
AuthorAffiliation_xml – name: Department of Endocrinology, 454 Hospital Affiliated to People's Liberation Army, Nanjing, Jiangsu Province, China
Author_xml – sequence: 1
  givenname: Zhiwei
  surname: Hu
  fullname: Hu, Zhiwei
  organization: Department of Endocrinology, 454 Hospital Affiliated to People's Liberation Army, Nanjing, Jiangsu Province, China
– sequence: 2
  givenname: Jin’an
  surname: Chen
  fullname: Chen, Jin’an
– sequence: 3
  givenname: Xinjuan
  surname: Sun
  fullname: Sun, Xinjuan
– sequence: 4
  givenname: Lei
  surname: Wang
  fullname: Wang, Lei
– sequence: 5
  givenname: Aiping
  surname: Wang
  fullname: Wang, Aiping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30946322$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv3CAUhVGVqplM-wsqVSy7cYp5mKGLSlEmfUiJuskeXWOcocXgGjyRd_3pJZmkjyyKkFjc852LzjlBRyEGi9DrmpzWRMl3V9tT8ufUXEnyDK1qwZpKqIYfoRUhVFRSSX6MTlL6VkRMUv4CHTOieMMoXaGfF33vDJgFxx7vXYbBBbzFaR5HbwcbMmQXAy73xi_GDs5gE0OeosdFmJfRYoo7B63NNuGxqAuT3uMzPNgMFQTwS3Lpzt2FbKd9GRdD8DjluXM2vUTPe_DJvnp41-j648X1-efq8uunL-dnl5VhTPBqw1suBGUdbLq-Y10rOXAiW5CqI2Ao5USJlnW9AthQMIIbylpJNsr2wFq2Rh8OtuPcDrYz5RsTeD1OboBp0RGc_ncS3E7fxL1uuGhIQ4vB2weDKf6Ybcp6cMlY7yHYOCdNKWE1r5uS_xq9-XvX7yWPqReBOgjMFFOabK-NOwRdVjuva6LvGtZXW_204cKyJ-yj_f8pfqBuoy8tpO9-vrWT3lnweXcvF1LRipJaEU4Eqe5J9guin7qW
CitedBy_id crossref_primary_10_3390_medicina58020194
crossref_primary_10_3390_molecules25092029
crossref_primary_10_1007_s40200_021_00814_2
crossref_primary_10_1177_1934578X20918687
crossref_primary_10_1210_clinem_dgab599
crossref_primary_10_3389_fnut_2020_574725
crossref_primary_10_1016_j_burnso_2024_03_003
crossref_primary_10_1097_TIN_0000000000000284
crossref_primary_10_2174_1573399817666210902144539
crossref_primary_10_1007_s12602_023_10051_z
crossref_primary_10_1080_13697137_2019_1682543
crossref_primary_10_1007_s10792_022_02333_2
crossref_primary_10_4103_ijnpnd_ijnpnd_54_24
crossref_primary_10_1038_s41387_021_00168_x
crossref_primary_10_23736_S2724_6507_20_03299_X
crossref_primary_10_3892_etm_2020_8525
crossref_primary_10_1111_joim_13399
crossref_primary_10_56294_saludcyt2022202
crossref_primary_10_1016_j_abb_2024_109911
crossref_primary_10_3390_nu14112295
crossref_primary_10_1007_s40200_022_01069_1
crossref_primary_10_1016_j_nut_2022_111674
crossref_primary_10_2174_1573401318666220404163302
crossref_primary_10_1007_s13410_022_01150_8
crossref_primary_10_3390_nu16213651
crossref_primary_10_3389_fnut_2024_1462535
crossref_primary_10_1007_s11154_020_09575_4
crossref_primary_10_23736_S2724_542X_21_02766_X
crossref_primary_10_1007_s12020_021_02671_8
crossref_primary_10_7759_cureus_58133
crossref_primary_10_3390_ijerph18062805
crossref_primary_10_3389_fendo_2023_1080138
crossref_primary_10_4239_wjd_v15_i2_209
crossref_primary_10_1111_dom_14299
crossref_primary_10_1007_s40200_023_01262_w
crossref_primary_10_4103_picr_picr_325_23
crossref_primary_10_1111_dom_15941
crossref_primary_10_1155_2024_9960656
crossref_primary_10_7759_cureus_17317
crossref_primary_10_3389_fnut_2022_1005786
crossref_primary_10_3390_biomedicines13010068
crossref_primary_10_1186_s12937_024_00914_8
crossref_primary_10_3389_fendo_2021_610893
crossref_primary_10_47419_bjbabs_v2i02_41
crossref_primary_10_1080_10408398_2021_1926220
crossref_primary_10_1186_s12902_022_01209_x
crossref_primary_10_7759_cureus_25919
crossref_primary_10_22141_2224_0721_19_1_2023_1241
crossref_primary_10_1016_j_diabres_2022_110037
crossref_primary_10_1080_10408398_2021_1997909
crossref_primary_10_3390_nu13124302
crossref_primary_10_1007_s11154_019_09522_y
crossref_primary_10_1111_ijcp_14779
crossref_primary_10_18231_j_ijpi_2021_027
crossref_primary_10_1186_s13098_023_01010_3
crossref_primary_10_3390_ijms242015485
crossref_primary_10_3390_nu13072288
crossref_primary_10_1080_10408398_2022_2028716
Cites_doi 10.2337/dc07-0292
10.1007/BF03347410
10.1111/dom.12625
10.2337/dc10-2167
10.2174/1573399812666151016101622
10.1111/j.1464-5491.2011.03510.x
10.1111/j.1464-5491.2012.03672.x
10.1007/BF00280883
10.1016/j.clnu.2013.01.020
10.1016/0197-2456(95)00134-4
10.1507/endocrj.EJ13-0356
10.1080/01616412.2017.1281199
10.2337/dc10-1632
10.1016/S0009-9120(99)00085-5
10.1186/2008-2231-20-10
10.1001/jama.2013.168118
10.1210/js.2018-00015
10.1038/ejcn.2014.251
10.1159/000342771
10.5717/jenb.2014.18.3.249
10.1016/j.jdiacomp.2016.06.017
10.2337/diacare.27.12.2813
10.4158/EP09300.OR
10.3945/ajcn.2009.28441
10.2337/dc10-2084
10.1155/2015/374178
10.1186/s12955-018-0873-3
10.1016/j.metabol.2014.06.008
10.1016/j.nut.2016.06.010
10.1007/s00394-009-0020-3
10.2337/db11-1360
10.1038/nrm2327
10.1007/s00125-010-1838-1
10.1016/S0140-6736(98)07019-6
10.1016/S0140-6736(16)31678-6
10.1152/ajpendo.00282.2009
10.1111/j.1753-0407.2011.00164.x
10.2337/dc10-0790
10.1038/ejcn.2011.181
10.2337/dc14-0180
10.1016/0895-4356(92)90054-Q
10.19082/2849
10.1111/j.1464-5491.2010.03092.x
ContentType Journal Article
Copyright the Author(s). Published by Wolters Kluwer Health, Inc.
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019
Copyright_xml – notice: the Author(s). Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000014970
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e14970
ExternalDocumentID PMC6456062
30946322
10_1097_MD_0000000000014970
00005792-201904050-00014
Genre Meta-Analysis
Comparative Study
Systematic Review
Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
.3C
.55
.GJ
1CY
53G
AAYXX
ADFPA
ADGHP
AE3
AFFNX
AFUWQ
BS7
BYPQX
CITATION
EJD
FW0
JF9
JG8
N4W
N~M
OCUKA
ODA
ORVUJ
OWU
P-K
R58
T8P
X7M
XXN
ZGI
ZXP
8L-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
7X8
5PM
ADSXY
ID FETCH-LOGICAL-c3354-84b45523da8dfd3db74a407ba79d0ac224095b3df9aa82ac54c23b7089efa3b3
ISSN 0025-7974
1536-5964
IngestDate Thu Aug 21 13:49:40 EDT 2025
Thu Jul 10 22:04:53 EDT 2025
Wed Feb 19 02:29:57 EST 2025
Tue Jul 01 03:28:54 EDT 2025
Thu Apr 24 23:07:26 EDT 2025
Fri May 16 03:57:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Language English
License http://creativecommons.org/licenses/by/4.0
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3354-84b45523da8dfd3db74a407ba79d0ac224095b3df9aa82ac54c23b7089efa3b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000014970
PMID 30946322
PQID 2203141615
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6456062
proquest_miscellaneous_2203141615
pubmed_primary_30946322
crossref_citationtrail_10_1097_MD_0000000000014970
crossref_primary_10_1097_MD_0000000000014970
wolterskluwer_health_00005792-201904050-00014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-April-01
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-April-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2019
Publisher the Author(s). Published by Wolters Kluwer Health, Inc
Wolters Kluwer Health
Publisher_xml – name: the Author(s). Published by Wolters Kluwer Health, Inc
– name: Wolters Kluwer Health
References Eftekhari (R21-20230914) 2011; 20
Hoseini (R43-20230914) 2016; 36
Mohammad (R32-20230914) 2016; 8
Kampmann (R25-20230914) 2014; 63
Parekh (R19-20230914) 2010; 16
Claudia (R9-20230914) 2011; 34
Mattila (R14-20230914) 2007; 30
Razzaghi (R34-20230914) 2016; 31
Alcubierre (R12-20230914) 2018; 16
Grimnes (R49-20230914) 2010; 27
Gambineri (R51-20230914) 2012; 61
Kim (R28-20230914) 2014; 18
Rad (R13-20230914) 2014; 43
Listed (R37-20230914) 1998; 352
Dalgård (R6-20230914) 2011; 34
Liu (R10-20230914) 2010; 91
Alcubierre (R45-20230914) 2015; 2015
Witham (R20-20230914) 2010; 53
Haroon (R44-20230914) 2015; 14
Muoio (R2-20230914) 2008; 9
Pittas (R7-20230914) 2010; 33
Ryu (R29-20230914) 2014; 61
George (R38-20230914) 2012; 29
Jung (R41-20230914) 2009; 297
Lotfy (R3-20230914) 2017; 13
Liu (R11-20230914) 2011; 66
Lo (R35-20230914) 2018; 2
Shargorodsky (R24-20230914) 2013; 32
Jorde (R18-20230914) 2009; 48
Sadiya (R31-20230914) 2015; 69
Robinson (R8-20230914) 2011; 34
Shehab (R48-20230914) 2012; 29
Hirai (R50-20230914) 2000; 85
Jehle (R27-20230914) 2014; 144
Forouhi (R33-20230914) 2016; 18
Disease (R1-20230914) 2016; 388
Follmann (R17-20230914) 1992; 45
Kamycheva (R42-20230914) 2007; 30
Xu (R52-20230914) 2013; 310
Ma (R39-20230914) 2017; 39
Herrmann (R46-20230914) 2014; 38
Nasri (R26-20230914) 2014; 3
Aksoy (R47-20230914) 2000; 33
Jadad (R36-20230914) 1996; 17
Matthews (R16-20230914) 1985; 28
Soric (R23-20230914) 2012; 4
Scragg (R5-20230914) 2004; 27
Acevedonegrete (R40-20230914) 2017; 7
Heshmat (R22-20230914) 2012; 20
Angellotti (R15-20230914) 2018; 2
Al-Zahrani (R30-20230914) 2014; 7
Mezza (R4-20230914) 2012; 61
References_xml – volume: 30
  start-page: 2569
  year: 2007
  ident: R14-20230914
  article-title: Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc07-0292
– volume: 7
  start-page: 5421
  year: 2014
  ident: R30-20230914
  article-title: A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus
  publication-title: Int J Clin Exp Med
– volume: 30
  start-page: 126
  year: 2007
  ident: R42-20230914
  article-title: Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03347410
– volume: 18
  start-page: 392
  year: 2016
  ident: R33-20230914
  article-title: Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12625
– volume: 34
  start-page: 1133
  year: 2011
  ident: R9-20230914
  article-title: Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years
  publication-title: Diabetes Care
  doi: 10.2337/dc10-2167
– volume: 14
  start-page: 1
  year: 2015
  ident: R44-20230914
  article-title: Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies
  publication-title: J Diabetes Metabol Disord
– volume: 13
  start-page: 3
  year: 2017
  ident: R3-20230914
  article-title: Chronic complications of diabetes mellitus: a mini review
  publication-title: Curr Diabetes Rev
  doi: 10.2174/1573399812666151016101622
– volume: 29
  start-page: 43
  year: 2012
  ident: R48-20230914
  article-title: D deficiency play a role in peripheral neuropathy in Type 2 diabetes
  publication-title: Diabetic Med
  doi: 10.1111/j.1464-5491.2011.03510.x
– volume: 29
  start-page: e142
  year: 2012
  ident: R38-20230914
  article-title: Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis
  publication-title: Diabetic Med
  doi: 10.1111/j.1464-5491.2012.03672.x
– volume: 28
  start-page: 412
  year: 1985
  ident: R16-20230914
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 32
  start-page: 970
  year: 2013
  ident: R24-20230914
  article-title: Effect of high doses of vitamin D on arterial properties, adiponectin and glucose homeostasis in type 2 diabetic patients
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2013.01.020
– volume: 17
  start-page: 1
  year: 1996
  ident: R36-20230914
  article-title: Assessing the quality of reports of randomized clinical trials: is blinding necessary
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(95)00134-4
– volume: 61
  start-page: 167
  year: 2014
  ident: R29-20230914
  article-title: A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea
  publication-title: Endocrine J
  doi: 10.1507/endocrj.EJ13-0356
– volume: 39
  start-page: 259
  year: 2017
  ident: R39-20230914
  article-title: Cognitive function and insulin resistance in elderly patients with type 2 diabetes
  publication-title: Neurol Res
  doi: 10.1080/01616412.2017.1281199
– volume: 34
  start-page: 628
  year: 2011
  ident: R8-20230914
  article-title: Lack of association between 25(OH)D levels and incident type 2 diabetes in older women
  publication-title: Diabetes Care
  doi: 10.2337/dc10-1632
– volume: 33
  start-page: 47
  year: 2000
  ident: R47-20230914
  article-title: Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy
  publication-title: Clin Biochem
  doi: 10.1016/S0009-9120(99)00085-5
– volume: 85
  start-page: 1951
  year: 2000
  ident: R50-20230914
  article-title: Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance
  publication-title: J Clin Endocrinol Metabol
– volume: 20
  start-page: 10
  year: 2012
  ident: R22-20230914
  article-title: Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial
  publication-title: Daru J Pharma Sci
  doi: 10.1186/2008-2231-20-10
– volume: 310
  start-page: 948
  year: 2013
  ident: R52-20230914
  article-title: Prevalence and control of diabetes in Chinese adults
  publication-title: JAMA J Am Med Assoc
  doi: 10.1001/jama.2013.168118
– volume: 2
  start-page: 310
  year: 2018
  ident: R15-20230914
  article-title: Vitamin D supplementation in patients with type 2 diabetes: the vitamin D for established type 2 diabetes (DDM2) study
  publication-title: J Endocrine Soc
  doi: 10.1210/js.2018-00015
– volume: 69
  start-page: 707
  year: 2015
  ident: R31-20230914
  article-title: Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2014.251
– volume: 61
  start-page: 337
  year: 2012
  ident: R4-20230914
  article-title: Vitamin D deficiency: a new risk factor for type 2 diabetes
  publication-title: Ann Nutr Metab
  doi: 10.1159/000342771
– volume: 18
  start-page: 249
  year: 2014
  ident: R28-20230914
  article-title: Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women
  publication-title: J Exerc Nutrition Biochem
  doi: 10.5717/jenb.2014.18.3.249
– volume: 31
  start-page: 766
  year: 2016
  ident: R34-20230914
  article-title: The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial
  publication-title: J Diabetes Complicat
  doi: 10.1016/j.jdiacomp.2016.06.017
– volume: 7
  start-page: 1
  year: 2017
  ident: R40-20230914
  article-title: The impact of parental history of type 2 diabetes on hyperinsulinemia and insulin resistance in subjects from central Mexico
  publication-title: Diabetes Metabol Syndr
– volume: 3
  start-page: 31
  year: 2014
  ident: R26-20230914
  article-title: Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial
  publication-title: J Renal Inj Prev
– volume: 27
  start-page: 2813
  year: 2004
  ident: R5-20230914
  article-title: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.12.2813
– volume: 16
  start-page: 600
  year: 2010
  ident: R19-20230914
  article-title: Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus
  publication-title: Endocr Pract
  doi: 10.4158/EP09300.OR
– volume: 91
  start-page: 1627
  year: 2010
  ident: R10-20230914
  article-title: Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.2009.28441
– volume: 34
  start-page: 1284
  year: 2011
  ident: R6-20230914
  article-title: Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians
  publication-title: Diabetes Care
  doi: 10.2337/dc10-2084
– volume: 2015
  start-page: 1
  year: 2015
  ident: R45-20230914
  article-title: Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus
  publication-title: J Diabetes Res
  doi: 10.1155/2015/374178
– volume: 16
  start-page: 44
  year: 2018
  ident: R12-20230914
  article-title: Vitamin D deficiency is associated with poorer satisfaction with diabetes-related treatment and quality of life in patients with type 2 diabetes: a cross-sectional study
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/s12955-018-0873-3
– volume: 63
  start-page: 1115
  year: 2014
  ident: R25-20230914
  article-title: Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial
  publication-title: Metab Clin Exp
  doi: 10.1016/j.metabol.2014.06.008
– volume: 36
  start-page: 54
  year: 2016
  ident: R43-20230914
  article-title: Vitamin D increases PPAR expression and promotes beneficial effects of physical activity in metabolic syndrome
  publication-title: Nutrition
  doi: 10.1016/j.nut.2016.06.010
– volume: 20
  start-page: 521
  year: 2011
  ident: R21-20230914
  article-title: Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients
  publication-title: Asia Pacific J Clin Nutr
– volume: 48
  start-page: 349
  year: 2009
  ident: R18-20230914
  article-title: Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels
  publication-title: Eur J Nutr
  doi: 10.1007/s00394-009-0020-3
– volume: 61
  start-page: 2369
  year: 2012
  ident: R51-20230914
  article-title: Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study
  publication-title: Diabetes
  doi: 10.2337/db11-1360
– volume: 43
  start-page: 1651
  year: 2014
  ident: R13-20230914
  article-title: The effects of vitamin D supplementation on glucose control and insulin resistance in patients with diabetes type 2: a randomized clinical trial study
  publication-title: Iranian J Public Health
– volume: 9
  start-page: 193
  year: 2008
  ident: R2-20230914
  article-title: Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2327
– volume: 53
  start-page: 2112
  year: 2010
  ident: R20-20230914
  article-title: The effect of different doses of vitamin D 3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial
  publication-title: Diabetologia
  doi: 10.1007/s00125-010-1838-1
– volume: 352
  start-page: 837
  year: 1998
  ident: R37-20230914
  article-title: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07019-6
– volume: 388
  start-page: 1545
  year: 2016
  ident: R1-20230914
  article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31678-6
– volume: 297
  start-page: E717
  year: 2009
  ident: R41-20230914
  article-title: A highly energetic process couples calcium influx through L-type calcium channels to insulin secretion in pancreatic beta-cells
  publication-title: Am J Physiol Endocrinol Metabol
  doi: 10.1152/ajpendo.00282.2009
– volume: 4
  start-page: 104
  year: 2012
  ident: R23-20230914
  article-title: Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: A pilot study
  publication-title: J Diabetes
  doi: 10.1111/j.1753-0407.2011.00164.x
– volume: 144
  start-page: w13942
  year: 2014
  ident: R27-20230914
  article-title: Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study
  publication-title: Swiss Med Wkly
– volume: 33
  start-page: 2021
  year: 2010
  ident: R7-20230914
  article-title: Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0790
– volume: 66
  start-page: 139
  year: 2011
  ident: R11-20230914
  article-title: Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the framingham offspring study
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2011.181
– volume: 38
  start-page: 521
  year: 2014
  ident: R46-20230914
  article-title: Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0180
– volume: 45
  start-page: 769
  year: 1992
  ident: R17-20230914
  article-title: Variance imputation for overviews of clinical trials with continuous response
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(92)90054-Q
– volume: 8
  start-page: 2849
  year: 2016
  ident: R32-20230914
  article-title: The effects of vitamin D supplementation on adiponectin level and insulin resistance in first-degree relatives of subjects with type 2 diabetes: a randomized double-blinded controlled trial
  publication-title: Electron Phys
  doi: 10.19082/2849
– volume: 27
  start-page: 1107
  year: 2010
  ident: R49-20230914
  article-title: Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow up
  publication-title: Diabetic Med
  doi: 10.1111/j.1464-5491.2010.03092.x
– volume: 2
  start-page: 1
  year: 2018
  ident: R35-20230914
  article-title: Effect of treating vitamin D deficiency in uncontrolled type 2 diabetes: a randomized, placebo-controlled study
  publication-title: Am J Ther
SSID ssj0013724
Score 2.5094895
SecondaryResourceType review_article
Snippet Conflicting evidence exists on the effect of vitamin D supplementation on glucose metabolism in subjects with type 2 diabetes (T2D). Therefore, this...
Supplemental Digital Content is available in the text
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e14970
SubjectTerms Blood Glucose - drug effects
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Female
Glycated Hemoglobin A - drug effects
Humans
Insulin - metabolism
Insulin Resistance - physiology
Randomized Controlled Trials as Topic
Systematic Review and Meta-Analysis
Vitamin D - administration & dosage
Vitamin D - therapeutic use
Vitamins - therapeutic use
Title Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-201904050-00014
https://www.ncbi.nlm.nih.gov/pubmed/30946322
https://www.proquest.com/docview/2203141615
https://pubmed.ncbi.nlm.nih.gov/PMC6456062
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTpomIcSdcpmMxFvJaGK7iR9hLZoQBSQ66FtkJy4LdOlEE03wxE_n-NakXYVgVRVVubr-PjvH9jnfQei5zNVADWQekETSgOYDEQhBGQxV4jhUOhLUZFGYvB-enNK3MzbrdH63vJbqSh5lv3bGlVwHVdgHuOoo2f9Adn1T2AG_AV_YAsKw_SeMx1r_QedrX-oV9kqcF2V_1F_pRJ3WKdyag2X_6-JnZrzgvWe69m7cmnx1Cqurtrk6cSvv2g59LRZVYd1yeUMGs7hxVlyqonEUcPEeRek9KXhDwU-1OTgrym91s_eLm7V-527jpiFC3vJeMZ3dUi_ur_rOud_GULU7Xp01l9uEPEfK97XDgHErYu47Y560SUd3dvJWPHgystqT9gMDPZuApAX7xbnBncAIdkhs9POWtvbHyfEQLMiBfonvRTDQiLpo78Pn8XjUrETFEV2n_YU_4JWrePxyRwkO0L5_3Kahc2X0ctUJ98alrcPvpgpbVs70Frrphif4leXabdRR5R2072lwF516yuHlHDvK4RHeohyGr6ccdpTDcKKmHI6wpxz2lLuHpm_G0-OTwGXmCDJCGA0SKiljEclFks9zLdFNBbRuKWIOrT3TZiJnkuRzLkQSiYzRLCIyHiRczQWR5D7qlstSPUQ4i-ciS7QkEBCBypDD63aoIj3XKaE-WQ9FvhbTzKnW6-Qpi9R7T0xG6TYKPfRifdGFFW35--nPPDwpdK56xUyUalmvUigHCfUUAJTjgYVrfUOPcw_FG0CuT9DC7ZtHyuLMCLg7zvVQsAF5akOfTflYzKNAtzN4yTKj_RDSR9d-0mN00LTZJ6hb_ajVUzCmK3loJqEOHev_AJd6xJo
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA-yByqI-O36GUH6ZLXbpk0r7MOy7bme11XY1TufSpKmunjXHrZ3cm_-6c606brroWAptJA0hEyazGR-8xtCnstcO9qRue2Fktksd4QtBPPBVOF8pDEStM2ikM6D2Ue2d-gfGrQFxsJg9Fl98hIf7TqNL5gPBw3D5XhvYc2Tg8W4tKaL6fiz9WHyJmnPqRElYcXj6qxorMm8xV_5PHJhDsCGBzpJGz2N-a53At_lzoDsvP-UJPFvfwN32Tq5K6jYPT9RxF-lccdx2F1gUGBe48097IJiehFfee1Hhb7v-lsLfd_YwHZvkOtG86STbqrcJJd0eYtcTo1v_Tb5mSCbhFDntCro2aoRx6uSxrTGtJ8dxBxlSOH-cnSuEFNPDc6dQkU8yqUu7Y9yqeFrrV_TCT3WDcjGsJ9g66sNoCV0qe6wjHfIcjdZTme2yc9gK8_zmR0yyXwwZHMR5kWORM1MgIyl4BHIXKGyEPnSy4tIiNAVymfK9SR3wkgXwpPeXTIoq1LfJ1TxQqgQiWEi0M_kKIJFN9AunnhJGG9_SNx-wDNluMsxhcZR1vvQ0zj7U0pD8mL90UlH3fHv6s96SWbwi6HfRJS6Oq0z6Ic3QkMQ-nGvk-y6QQ_M4wAWxSHhWzJfV0D67u2ScvW1pfEOQHd1AvjS3podWRcAm_1tDj_4z_pPyZXZMt3P9t_O3z0kV7G0Qx49IoPm-6l-DEpVI5-YP-IXMOoW_w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA7LLCyCiHfHawTpk5VOkzat0Idh2nFdndmFGXV9Kkma6uBuu9juyrz50z2nl3HHFcFSaKFpCDlN-p2cL98h5IXKjGMcldksUNzmmSNtKbkHrooQI4M7QZssCrO5v_-BHxx7xzukj5ji5rPq7BVemmkabzAdDvqFy-hgYU0Wk-izNU8-LaK5dTR-kzTL1EiSsI7iabS24qi8yGsrPox6fcZZ3IoUtgd4BAJc_N0g8B0-ILuHH5Mk_h13EC7fJHkFqN3rFP29mu1_2RWAepVnef1HiTHw6ltDgb_0I5veJDc6BErH7Sdzi-yY4jbZm3Ux9jvkZ4KqElKvaZnTi1UtT1cFjWmF6T9bqjnaksL55WStkVtPO747hYK4pEtd2i_p0k63tXpNx_TU1GCjTgUFa19dIlxCk6qW03iXLKfJcrJvd3kabM2Yx-2AK-6BQ5vJIMszFGzmEmytpAjB9hpBQ-gpluWhlIErtce1y5RwgtDkkil2jwyKsjAPCNUilzpAgZgQcJoahTD5-sbFlS8F_e0Nidt3eKo7DXNMpXGS9rH0WZz-aaUhebl56ayV8Ph38ee9JVMYahg_kYUpz6sU2sFG6BBCO-63lt1UyMBN9mFyHBKxZfNNAZTx3n5SrL42ct4-YFjHhzftra8jbTfCNu3zROjCfAbgDfB1owQw4g__s_wzsgcjJH3_dv7uEbmGD1sC0mMyqL-fmyeArWr1tBsQvwB9kBiQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+vitamin+D+supplementation+on+glycemic+control+in+type+2+diabetes+patients&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Hu%2C+Zhiwei&rft.au=Chen%2C+Jin%E2%80%99an&rft.au=Sun%2C+Xinjuan&rft.au=Wang%2C+Lei&rft.date=2019-04-01&rft.pub=Wolters+Kluwer+Health&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=98&rft.issue=14&rft_id=info:doi/10.1097%2FMD.0000000000014970&rft_id=info%3Apmid%2F30946322&rft.externalDocID=PMC6456062
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon